share_log

ThinkEquity Initiates Coverage On BioVie With Buy Rating, Announces Price Target of $3

ThinkEquity Initiates Coverage On BioVie With Buy Rating, Announces Price Target of $3

ThinkEquity开启了BioVie的买入评级,并宣布目标价为3美元
Benzinga ·  07/01 06:52

ThinkEquity analyst Ashok Kumar initiates coverage on BioVie (NASDAQ:BIVI) with a Buy rating and announces Price Target of $3.

ThinkEquity分析师Ashok Kumar开始对BioVie (纳斯达克股票代码:BIVI)进行买入评级,并宣布目标价为3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发